Gene · 2046
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prostate cancer cell-platelet bidirectional signaling promotes calcium mobilization, invasion and apoptotic resistance via distinct receptor-ligand pairs. | Sci Rep | 2023 | 36806315 | PubTator, text mining | PubMed |
| Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection. | Immunobiology | 2023 | 36805858 | PubTator, text mining | PubMed |
| Prediction of prime editing insertion efficiencies using sequence features and DNA repair determinants. | Nat Biotechnol | 2023 | 36797492 | PubTator, text mining | PubMed |
| Neutron Reflectometry and Molecular Simulations Demonstrate HIV-1 Nef Homodimer Formation on Model Lipid Bilayers. | J Mol Biol | 2023 | 36773691 | PubTator, text mining | PubMed |
| The expression of SERPINE1 in colon cancer and its regulatory network and prognostic value. | BMC Gastroenterol | 2023 | 36755247 | PubTator, text mining | PubMed |
| Metformin use history and genome-wide DNA methylation profile: potential molecular mechanism for aging and longevity. | Aging (Albany NY) | 2023 | 36734879 | PubTator, text mining | PubMed |
| Flavonoids as Modulators of Potassium Channels. | Int J Mol Sci | 2023 | 36674825 | PubTator, text mining | PubMed |
| THSD7A Positivity Is Associated with High Expression of FAK in Prostate Cancer. | Diagnostics (Basel) | 2023 | 36673031 | PubTator, text mining | PubMed |
| Development of a versatile nuclease prime editor with upgraded precision. | Nat Commun | 2023 | 36658146 | PubTator, text mining | PubMed |
| Polypharmacology of ambroxol in the treatment of COVID-19. | Biosci Rep | 2023 | 36651548 | PubTator, text mining | PubMed |
| Enhancement of a prime editing system via optimal recruitment of the pioneer transcription factor P65. | Nat Commun | 2023 | 36650182 | PubTator, text mining | PubMed |
| Identifying cancer driver genes based on multi-view heterogeneous graph convolutional network and self-attention mechanism. | BMC Bioinformatics | 2023 | 36639646 | PubTator, text mining | PubMed |
| A novel drug-like water-soluble small molecule Focal Adhesion Kinase (FAK) activator promotes intestinal mucosal healing. | Curr Res Pharmacol Drug Discov | 2023 | 36632414 | PubTator, text mining | PubMed |
Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type. | Cell Mol Biol Lett | 2023 | 36609218 | PubTator, text mining | PubMed |
| The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer. | Cancer Chemother Pharmacol | 2023 | 36598552 | PubTator, text mining | PubMed |
| Modifiable contributing factors to COVID-19: A comprehensive review. | Food Chem Toxicol | 2023 | 36450305 | PubTator, text mining | PubMed |
| Finnish-specific AKT2 gene variant leads to impaired insulin signalling in myotubes. | J Mol Endocrinol | 2023 | 36409629 | PubTator, text mining | PubMed |
| Role of antioxidants in fertility preservation of sperm - A narrative review. | Anim Biosci | 2023 | 36397685 | PubTator, text mining | PubMed |
| The role of Nod-like receptor protein 3 inflammasome activated by ion channels in multiple diseases. | Mol Cell Biochem | 2023 | 36378463 | PubTator, text mining | PubMed |
| Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics. | Mol Aspects Med | 2023 | 36371228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2046/papers?page=10